v3.26.1
BUSINESS ACQUISITION AND RERVERSE RECAPITALIZATION - Reverse Recapitalization (Details)
 12 Months Ended
Oct. 01, 2024
D
$ / shares
shares
Sep. 30, 2024
USD ($)
$ / shares
shares
Aug. 03, 2023
period
D
$ / shares
Dec. 31, 2024
USD ($)
$ / shares
shares
Dec. 31, 2025
$ / shares
shares
Dec. 31, 2023
shares
BUSINESS ACQUISITION AND RERVERSE RECAPITALIZATION            
Ordinary shares outstanding 29,411,765 29,411,765   25,555,096 30,752,370 29,411,765
Conversion of original Baird Medical Investment Holdings Limited Shareholders ordinary shares 20,588,236          
Percentage of outstanding common stock, vested and freely tradable 70.00%          
Common stock shares, to be held, subject to vesting and forfeiture 8,823,529          
Percentage of outstanding common stock, subject to vesting and forfeiture 30.00%          
Ordinary shares price (in dollars per share) | $ / shares     $ 12.5      
Number of trading days | D 20   20      
Number of trading period 30   30      
Ordinary shares, par value (in dollars per share) | $ / shares     $ 0.0001 $ 0.0001 $ 0.0001  
Exercise price of warrants (in dollars per share) | $ / shares     11.5      
Preferred stock, par value (in dollars per share) | $ / shares       $ 0.0001 $ 0.0001  
Proceeds from PIPE investment | $       $ 2,900,000    
Preferred shares            
BUSINESS ACQUISITION AND RERVERSE RECAPITALIZATION            
PIPE financing (in shares)       290,000    
GFC | Series A Preferred Shares            
BUSINESS ACQUISITION AND RERVERSE RECAPITALIZATION            
PIPE financing (in shares)   290,000        
Preferred stock, par value (in dollars per share) | $ / shares   $ 0.0001        
Proceeds from PIPE investment | $   $ 2,900,000        
ExcelFin Acquisition Corp.            
BUSINESS ACQUISITION AND RERVERSE RECAPITALIZATION            
Conversion of original Baird Medical Investment Holdings Limited Shareholders ordinary shares 20,588,236          
Ordinary shares price (in dollars per share) | $ / shares     $ 11.5      
Number of trading period | D 30          
Number of shares issued 5,750,000          
Number of shares issued and not vested till fifth anniversary 1,350,000          
Conversion of working capital loan ordinary shares 278,406          
Conversion of public shareholders ordinary shares 288,454          
Conversion of working capital loan ordinary shares (in dollars per share) | $ / shares $ 10.2          
ExcelFin Acquisition Corp. | Public warrants            
BUSINESS ACQUISITION AND RERVERSE RECAPITALIZATION            
Number of warrants exercisable 11,500,000          
Warrant exercisable term 30 days          
Period of warrants and rights outstanding 5 years          
Number of shares per warrant 1          
Exercise price of warrants (in dollars per share) | $ / shares $ 11.5          
ExcelFin Acquisition Corp. | Public stockholders            
BUSINESS ACQUISITION AND RERVERSE RECAPITALIZATION            
Ordinary shares, par value (in dollars per share) | $ / shares 0.0001          
Minimum            
BUSINESS ACQUISITION AND RERVERSE RECAPITALIZATION            
Ordinary shares price (in dollars per share) | $ / shares 12.5          
Minimum | ExcelFin Acquisition Corp.            
BUSINESS ACQUISITION AND RERVERSE RECAPITALIZATION            
Ordinary shares price (in dollars per share) | $ / shares $ 12.5